주술기 관리
수혈의 위험성 및 불확실성
Blood transfusion and cancer surgery outcomes: a continued reason for concern. (새로운 창 열기)
Source: Surgery 2012;152(3):344-54.
Indexed: PubMed 22938895
DOI: 10.1016/j.surg.2012.06.008
Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (새로운 창 열기)
Source: Arch Surg 2012;147(1):49-55.
Indexed: PubMed 22250113
DOI: 10.1001/archsurg.2011.790
Adverse blood transfusion outcomes: establishing causation. (새로운 창 열기)
Source: Transfus Med Rev 2011;25(2):89-101.
Indexed: PubMed 21345639
DOI: 10.1016/j.tmrv.2010.11.001
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (새로운 창 열기)
Source: Crit Care Med 2006;34(6):1608-16.
Indexed: PubMed 16607235
DOI: 10.1097/01.CCM.0000217920.48559.D8
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (새로운 창 열기)
Source: Crit Care Med 2008;36(9):2667-74.
Indexed: PubMed 18679112
DOI: 10.1097/CCM.0b013e3181844677
Survival rate changes with transfusion of blood products during liver transplantation. (새로운 창 열기)
Source: Can J Anaesth 2005;52(2):148-55.
Indexed: PubMed 15684254
DOI: 10.1007/BF03027720
Emerging infectious disease agents and their potential threat to transfusion safety. (새로운 창 열기)
Source: Transfusion 2009;49 Suppl 2:1S-29S.
Indexed: PubMed 19686562
DOI: 10.1111/j.1537-2995.2009.02279.x
Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (새로운 창 열기)
Source: ISBT Sci Ser 2014;9(1):30-6.
Indexed: PubMed 25210533
DOI: 10.1111/voxs.12070
